Pelthos Therapeutics Inc (PTHS) Stock Price, Quote & News

Company Profile

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indi...

Industry: Biotechnology

Sector: Healthcare

Phone: 919 908 2400

Website: pelthos.com

Address:

4020 Stirrup Creek Drive, Suite 110, Durham, United States

twib Apr. 16 at 5:56 PM

$PTHS Think we've disappeared from mkt:) At least on st I havent seen it move even a penny off $23. 🤯🤦‍♂️

0 · Reply

twib Apr. 15 at 1:54 PM

$PTHS One 100 shr buy tday, the rest are all 1 shr. 181 in 1st half hour. Waiting for the day our little baby will get noticed.

0 · Reply

OfficialStocktwitsUser Apr. 9 at 10:48 PM

$PTHS RSI: 48.54, MACD: -0.2166 Vol: 1.24, MA20: 22.55, MA50: 22.89 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

twib Apr. 6 at 7:44 PM

$PTHS Up large tday on 3x avg volume. Jw apprec the #s as always. We movin😯

0 · Reply

Jwa68 Apr. 6 at 5:48 PM

$PTHS 834 units the week before last. Up 10% from the prior week. Executing!!

2 · Reply

twib Apr. 6 at 3:28 PM

$PTHS 😁 This will eventually get volume flow up. Guessing very little tday causing. Might need to have patience for a good yr or so but...

1 · Reply

Jwa68 Apr. 1 at 2:16 PM

$PTHS Cantor note out, very bullish. "Under the radar commercial launch story that is starting to inflect and we believe the current valuation does not reflect it at all." Target $50

0 · Reply

Jwa68 Mar. 31 at 1:09 PM

$PTHS Continued execution by management. Shares remain very undervalued.

0 · Reply

DARKP00L Mar. 31 at 12:45 PM

$PTHS 08:31 on Mar. 31 2026 Pelthos Therapeutics Announces First Patient Dosed In Phase 1b/2a Clinical Trial Evaluating CT2000 As Potential Treatment For Eye Pain #tradeideas

0 · Reply

mateo86 Mar. 27 at 3:25 PM

$PTHS Nothing like a$8000 swing to start the weekend. Holding for the big $$$$

0 · Reply

Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain

Mar 19, 2026, 6:30 AM EDT - 4 weeks ago

Pelthos Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results

Mar 12, 2026, 8:30 AM EDT - 5 weeks ago

Pelthos Therapeutics to Present at 38th Annual ROTH Conference

Jan 15, 2026, 4:10 PM EST - 3 months ago

Horizon Technology Finance Provides up to $50 Million Venture Loan Facility to Pelthos Therapeutics

HRZN

Jan 13, 2026, 8:30 AM EST - 3 months ago

Pelthos Therapeutics Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance

Jan 5, 2026, 7:30 AM EST - 3 months ago

Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice

Nov 13, 2025, 6:45 AM EST - 5 months ago

Pelthos Therapeutics Announces Third Quarter Fiscal 2025 Financial Results

Nov 7, 2025, 8:00 AM EST - 5 months ago

Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing

Nov 5, 2025, 8:00 AM EST - 5 months ago

Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025

Sep 8, 2025, 8:30 AM EDT - 7 months ago

Pelthos Therapeutics to Participate in Upcoming September Investor Conferences

Aug 18, 2025, 8:00 AM EDT - 8 months ago

Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update

twib Apr. 16 at 5:56 PM

$PTHS Think we've disappeared from mkt:) At least on st I havent seen it move even a penny off $23. 🤯🤦‍♂️

0 · Reply

twib Apr. 15 at 1:54 PM

$PTHS One 100 shr buy tday, the rest are all 1 shr. 181 in 1st half hour. Waiting for the day our little baby will get noticed.

0 · Reply

OfficialStocktwitsUser Apr. 9 at 10:48 PM

0 · Reply

twib Apr. 6 at 7:44 PM

$PTHS Up large tday on 3x avg volume. Jw apprec the #s as always. We movin😯

0 · Reply

Jwa68 Apr. 6 at 5:48 PM

$PTHS 834 units the week before last. Up 10% from the prior week. Executing!!

2 · Reply

twib Apr. 6 at 3:28 PM

$PTHS 😁 This will eventually get volume flow up. Guessing very little tday causing. Might need to have patience for a good yr or so but...

1 · Reply

Jwa68 Apr. 1 at 2:16 PM

$PTHS Cantor note out, very bullish. "Under the radar commercial launch story that is starting to inflect and we believe the current valuation does not reflect it at all." Target $50

0 · Reply

Jwa68 Mar. 31 at 1:09 PM

$PTHS Continued execution by management. Shares remain very undervalued.

0 · Reply

DARKP00L Mar. 31 at 12:45 PM

$PTHS 08:31 on Mar. 31 2026 Pelthos Therapeutics Announces First Patient Dosed In Phase 1b/2a Clinical Trial Evaluating CT2000 As Potential Treatment For Eye Pain #tradeideas

0 · Reply

mateo86 Mar. 27 at 3:25 PM

$PTHS Nothing like a$8000 swing to start the weekend. Holding for the big $$$$

0 · Reply

twib Mar. 23 at 6:22 PM

$PTHS Didnt 5hink she would stay so low but still hoping it drops even harder. Gimme cheapies tk u very much!

0 · Reply

Jwa68 Mar. 20 at 7:38 PM

$PTHS A picture is worth a thousand words.

1 · Reply

StreetwiseReports Mar. 20 at 7:14 PM

Durham, NC Biopharma Co. Finds High-Growth Drug Opportunity https://ow.ly/POjy50YwZ8R Pelthos Therapeutics Inc. ( $PTHS ) delivered massive growth from its drug launch, with bullish forecasts signaling upside, according to analysts.

0 · Reply

erevnon Mar. 20 at 3:22 PM

Oppenheimer maintains Pelthos Therapeutics $PTHS at Outperform and raises the price target from $60 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

Jwa68 Mar. 20 at 3:13 PM

$PTHS Oppenheimer raises to a $62 target. Deep value. 756 for last week...executing.

0 · Reply

mateo86 Mar. 20 at 2:49 PM

$PTHS literally nothing changed between after the actual end of 4th quarter and earnings report. If anything the numbers have gotten way better since then....

1 · Reply

Slapshot22 Mar. 19 at 7:11 PM

$PTHS Decent enough data in the PR and call, and the SP is down. Then you look at volume. 6k on ER day? Am I reading that right? The stock no one is watching … Yet. Just a small position for me, but we will see.

1 · Reply

topstockalerts Mar. 19 at 1:06 PM

$PTHS been basing for a bit, looks like it’s trying to hold a higher floor. If it reclaims momentum, could get a clean breakout move with the right trigger.

0 · Reply

Jwa68 Mar. 19 at 12:58 PM

$PTHS Evcellent results and excellent conference call. The team is incredibly competent and doing exactly as promised. Worth a listen to the replay.

0 · Reply

StocktwitsEarnings Mar. 19 at 11:57 AM

$PTHS Q4 '25 Earnings Results & Recap Pelthos Therapeutics Inc. reported a net loss of approximately $43.3M for the year ended December 31, 2025, with net product revenues of $16.2M from ZELSUVMI, and total operating expenses of $49.2M.

0 · Reply

mateo86 Mar. 17 at 2:48 PM

$PTHS

0 · Reply

SonOfOdinX Mar. 11 at 9:28 PM

$PTHS

0 · Reply

Market Cap	77.23M
Revenue (ttm)	16.80M
Net Income (ttm)	-43.32M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-257.86%
Debt to Equity Ratio	0.00

Volume	16,700
Avg Vol	8,380
Day's Range	N/A - N/A
Shares Out	3.36M
Stochastic %K	38%
Beta	3.93
Analysts	Strong Sell
Price Target	$57.14